These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25525201)

  • 21. Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
    Lahiri SD; Bradford PA; Nichols WW; Alm RA
    J Antimicrob Chemother; 2016 Oct; 71(10):2848-55. PubMed ID: 27402011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections.
    Falcone M; Paterson D
    J Antimicrob Chemother; 2016 Oct; 71(10):2713-22. PubMed ID: 27432599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria.
    Asli A; Brouillette E; Krause KM; Nichols WW; Malouin F
    Antimicrob Agents Chemother; 2016 Feb; 60(2):752-6. PubMed ID: 26574008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria.
    Edoo Z; Iannazzo L; Compain F; Li de la Sierra Gallay I; van Tilbeurgh H; Fonvielle M; Bouchet F; Le Run E; Mainardi JL; Arthur M; Ethève-Quelquejeu M; Hugonnet JE
    Chemistry; 2018 Jun; 24(32):8081-8086. PubMed ID: 29601108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens.
    Bush K
    Int J Antimicrob Agents; 2015 Nov; 46(5):483-93. PubMed ID: 26498989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam.
    Wang DY; Abboud MI; Markoulides MS; Brem J; Schofield CJ
    Future Med Chem; 2016 Jun; 8(10):1063-84. PubMed ID: 27327972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftazidime-avibactam for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
    Mawal Y; Critchley IA; Riccobene TA; Talley AK
    Expert Rev Clin Pharmacol; 2015; 8(6):691-707. PubMed ID: 26420166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
    J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
    Kaushik A; Gupta C; Fisher S; Story-Roller E; Galanis C; Parrish N; Lamichhane G
    Future Microbiol; 2017 May; 12(6):473-480. PubMed ID: 28326811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections.
    Alidjanov JF; Fritzenwanker M; Hoffman I; Wagenlehner FM
    Future Microbiol; 2017 Jun; 12():655-670. PubMed ID: 28338347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition Activity of Avibactam against Nocardia farcinica β-Lactamase FAR
    Lebeaux D; Ourghanlian C; Dorchène D; Soroka D; Edoo Z; Compain F; Arthur M
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712200
    [No Abstract]   [Full Text] [Related]  

  • 33. Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor.
    Ehmann DE; Jahić H; Ross PL; Gu RF; Hu J; Kern G; Walkup GK; Fisher SL
    Proc Natl Acad Sci U S A; 2012 Jul; 109(29):11663-8. PubMed ID: 22753474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.
    Singh R; Kim A; Tanudra MA; Harris JJ; McLaughlin RE; Patey S; O'Donnell JP; Bradford PA; Eakin AE
    J Antimicrob Chemother; 2015 Sep; 70(9):2618-26. PubMed ID: 26024868
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.
    Lahiri SD; Mangani S; Jahić H; Benvenuti M; Durand-Reville TF; De Luca F; Ehmann DE; Rossolini GM; Alm RA; Docquier JD
    ACS Chem Biol; 2015 Feb; 10(2):591-600. PubMed ID: 25406838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
    Hidalgo JA; Vinluan CM; Antony N
    Drug Des Devel Ther; 2016; 10():2379-86. PubMed ID: 27528799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the
    Kaushik A; Ammerman NC; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.
    Sayed ARM; Shah NR; Basso KB; Kamat M; Jiao Y; Moya B; Sutaria DS; Lang Y; Tao X; Liu W; Shin E; Zhou J; Werkman C; Louie A; Drusano GL; Bulitta JB
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106266
    [No Abstract]   [Full Text] [Related]  

  • 40. Select β-Lactam Combinations Exhibit Synergy against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.